Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review Luis Gutiérrez-Rojas; Jesús José de la Gándara Martín; Luisa García Buey; Juan I. Uriz Otano; Álvaro Mena; Carlos Roncero;

Artificial intelligence-assisted identification and retrieval of chronic hepatitis C patients lost to follow-up in the health area of Pontevedra and O Salnés (Spain) Pablo Parada Vázquez; Santiago Pérez-Cachafeiro; Belén Castiñeira Domínguez; Juan Manuel González-Pérez; José Manuel Mera Calviño; Raquel Souto-Rodríguez; Yolanda Falagán Cachafeiro; Indhira Pérez-Medrano; Nuria Vázquez-Temprano; Matilde Trigo; Alba Carrodeguas; José Luis González-Sánchez; Carmen Durán-Parrondo; Juan Turnes;

Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 years Rafael Esteban; Raquel Domínguez-Hernández; Helena Cantero; Miguel Ángel Casado;